OxThera is a clinical stage biotechnology company with its first product in phase III. The company is based in Sweden (Uppsala) and Florida (Gainesville). The company develops products, based on its cell- and enzyme based proprietary technologies,...

Total money raised: $56.8M

753 20 Dragarbrunnsgatan 45


Phone: 46-018-24-4045

Updated on Apr 16, 2014
OxThera at CrunchBase
Elisabeth Lindner CEO
Staffan Lindstrand Board Member

April, 2014

OxThera raised $10.3M in unattributed round from IDInvest Partners

OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs

June, 2007

OxThera raised $22.1M in unattributed round from HealthCap, Q-Med, Industrifonden, and SLS Venture

OxThera Raises SEK 150 Million in New Round of Financing

July, 2005

OxThera raised $24.4M in unattributed round from HealthCap and SLS Venture

External financing of SEK 165 million secured for Q-Med's oxalate project